S3L (p.Ser3Leu) variant of BAK1 (Q16611)

S3L (p.Ser3Leu) in BAK1 (Q16611) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.47 / 1. The record also includes population frequency data and structural context.

S3L (p.Ser3Leu) variant details